The Slide That Calms Every Board
Somewhere in your Q2 board deck is a slide that says “Pipeline Coverage: 3.4x.” It’s probably on page six, nestled between the ARR waterfall and the hiring plan. The CEO presents it with measured confidence. The board members nod. Someone might ask about coverage by segment or by rep. The VP of Sales gives a crisp answer. Everyone moves on to the next slide.
Nobody in that room questioned whether 3.4x means anything.
It doesn’t.
Or more precisely – it means exactly one thing: for every dollar of quota, there are $3.40 worth of deals somewhere in the CRM. That’s it. That’s all it tells you. It says nothing about whether those deals are real. Nothing about whether the buyers have confirmed a problem. Nothing about whether anyone with authority to sign has been identified. Nothing about whether there’s an actual reason to buy this quarter versus next quarter versus never.
Pipeline coverage is a volume metric dressed up as a health metric. And SaaS companies worship it like it’s scripture.
How SaaS Got Addicted To This Number
Pipeline coverage became gospel for the same reason most bad metrics survive: it’s easy to calculate, easy to present, and easy to improve. Want better coverage? Generate more pipeline. More SDR activity, more sequences, more events, more demos. The inputs are obvious and the output moves in the right direction.
SaaS operators love this because it creates the illusion of control. Board is nervous about next quarter? Show them 4x coverage. Investors asking about growth trajectory? Point to the pipeline. New VP of Sales wants to prove they’re making an impact? Pump the coverage number in their first ninety days.
The entire SaaS revenue machine – SDRs, marketing, demand gen, BDRs, partnerships – is optimized to feed this one metric. And nobody stops to ask the question that would unravel the whole thing: what percentage of this pipeline is going to close?
Because if you ask that question honestly, the answer is brutal. Industry data across SaaS companies says average win rates sit between 15-25%. Which means 3x coverage isn’t a safety margin. It’s an admission that 70-80% of your pipeline is waste. You’re not building a revenue engine. You’re building a recycling center and measuring the intake instead of the output.
The Coverage Trap In Action
Here’s what 3x pipeline coverage actually looks like inside a real SaaS revenue org.
Your $5M quarterly target needs $15M in pipeline. Your team generates it. Looks great in the deck. Now let’s open the CRM and see what’s actually in there.
$4M is “early stage” pipeline – deals that had a first or second meeting, showed some interest, and were optimistically staged by reps who know their manager checks pipeline volume every Friday. Half of these deals will go dark within thirty days. The other half will sit in Stage 1 until someone mercifully deletes them during a quarterly cleanup. Contribution to revenue this quarter: approximately zero.
$5M is “mid-stage” pipeline – deals in Stage 2 or 3 that have had multiple conversations. These look real from the outside. But pull the thread and you’ll find that most of them are single-threaded to a champion with no buying authority, have no documented timeline for a decision, and have never discussed budget or cost of inaction. The reps are working them because activity feels like progress. The deals aren’t advancing because there’s nothing forcing them to advance.
$4M is “late stage” pipeline – deals in Stage 4 or 5 that should be closing. Some of them will. But at least $1.5M of this has been in “late stage” for more than sixty days. That’s not late stage. That’s stalled. Deals don’t sit in Stage 4 for two months because the buyer is carefully evaluating. They sit there because something is wrong – a stakeholder objected, budget got frozen, the champion left, a competitor showed up – and nobody on the selling side has diagnosed what happened. They just keep “following up” and hoping.
$2M is “commit” – deals the rep has flagged as closing this quarter. Some of these will close. Others are in commit because the rep’s manager told them they needed more commit and the rep picked the deals that felt closest. Commit in most SaaS orgs isn’t a rigorous assessment of buyer readiness. It’s a confidence survey administered under pressure.
Add it all up. $15M in coverage. Maybe $3-4M that’s actually going to close. The real coverage isn’t 3x. It’s 0.8x. And the company won’t discover that until week eleven of a thirteen-week quarter, when the deals that were supposed to close don’t, and the Monday forecast call turns into a Monday panic call.
What The Number Should Actually Measure
Pipeline coverage isn’t useless. It’s incomplete. The number itself is fine as a top-of-funnel volume indicator. The problem is when SaaS companies treat it as a proxy for revenue health. It isn’t. Revenue health requires a second dimension that almost nobody measures: pipeline quality.
Quality means something specific. It means every deal counted in the coverage number has been verified against criteria that predict whether it will actually close. Not “the rep thinks it’s real.” Not “there’s been activity recently.” Verified. Documented. Reviewable.
Does the buyer acknowledge a problem severe enough to act on this quarter? Has someone with the authority to approve the purchase been identified and engaged? Is there an external forcing function – a contract expiration, a board mandate, a compliance deadline – creating urgency independent of the seller’s follow-up cadence? Has the cost of doing nothing been quantified in terms the buyer owns and agrees to?
When you filter pipeline through those criteria, the number shrinks dramatically. And that’s terrifying for SaaS revenue leaders because a smaller number means the board slide looks worse. But here’s the part that matters: the smaller number is actually predictive. A pipeline of $6M where every deal has been qualified against real criteria will outperform a pipeline of $15M where stage assignments are vibes and commit is a confidence poll. Every single time.
Why SaaS Boards Won’t Ask The Hard Question
Board members know this, by the way. At least the good ones do. They’ve seen enough quarters miss with “healthy” coverage to know the number is soft. But they don’t push on it for a reason that has nothing to do with naivete and everything to do with incentives.
Questioning pipeline coverage means questioning the entire demand generation engine. It means asking whether the SDR team generating all that top-of-funnel is actually producing revenue or producing the appearance of revenue. It means asking whether the marketing budget that feeds the pipeline is an investment or an expense. It means looking at the VP of Sales and asking, “If we filtered your pipeline for deals where the buyer has actually confirmed the cost of doing nothing, what number would I be looking at?”
That question will ruin a board meeting. It will also save a company.
Because the SaaS companies that eventually figure this out – the ones that move from coverage-based forecasting to quality-based forecasting – stop having surprise misses. They stop the quarterly scramble. They stop blaming “long sales cycles” and “tough market conditions” for outcomes that were actually predictable eight weeks in advance if anyone had been looking at the right data.
The Audit You Can Run This Week
Pull up your pipeline right now. Pick the ten largest deals in Stage 3 or later. For each one, answer these four questions:
One: Has the buyer explicitly told you – not implied, not hinted, told you – that this problem is severe enough to justify spending money on it this quarter?
Two: Have you spoken directly with the person who can approve the purchase? Not the champion. Not the technical evaluator. The person who signs.
Three: Is there a deadline driving this decision that exists independently of your sales cycle? A contract expiration, a regulatory requirement, a board mandate – something the buyer has to respond to whether your product exists or not?
Four: Has the buyer quantified what it costs them to do nothing? Not your ROI model. Not your business case template. Their number. The one they calculated or confirmed.
For any deal where the answer to all four is yes, you have a real deal. Put it in the forecast with confidence.
For everything else – and this is the hard part – you have a pipeline entry, not a deal. It might become a deal. It might not. But counting it in your coverage number and presenting it to your board as revenue potential is the same as counting lottery tickets as income. Technically it could happen. Operationally it’s a fantasy.
The SaaS companies that grow predictably aren’t the ones with the biggest pipelines. They’re the ones who know the difference between a deal and a wish – and have the discipline to only count the deals.
I help B2B companies fix the revenue systems that legacy methodologies broke. If something in this post made you uncomfortable, it was probably the part that's true. Stop the bleeding.
